|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 143.90 GBX | -1.44% |
|
+0.98% | +12.42% |
| Feb. 06 | Hargreave Hale AIM asset value falls after "eventful" first quarter | AN |
| Jan. 15 | TruFin lifts outlook, Abingdon reports revenue gain | AN |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Life Sciences Tools and Services | ||||||||||
Medical Labs & Research | 12.7M | 13.94M | 19.5M | 23.7M | 32.16M | |||||
Total Assets | 43.52M | 45.01M | 48.26M | 46.34M | 48.62M | |||||
Interest Expense | -41K | -88K | -120K | -66K | -54K | |||||
Income Tax Expense | -945K | -99K | -160K | -692K | -205K | |||||
CAPEX | -6.29M | -5.6M | -4.87M | -125K | -100K | |||||
EBT | -682K | 462K | 564K | -2.44M | -1.91M | |||||
Gross Profit | 9.46M | 10.73M | 16.74M | 19.71M | 28.27M | |||||
D&A | 695K | 1.02M | 1.66M | 3.27M | 3.16M | |||||
Operating Income | -658K | 550K | 575K | -3.02M | -2.46M | |||||
Net Income | 263K | 561K | 724K | -1.75M | -1.7M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
North America | - | 8.46M | 14.45M | 20.83M | 29.54M | |||||
Europe | 4.24M | 3.62M | 2.7M | 2.47M | 1.89M | |||||
UK | 543K | 555K | 561K | 352K | 547K | |||||
Asia and Rest of World | - | 1.31M | 1.79M | 45K | 181K | |||||
Asia | 1.88M | - | - | - | - | |||||
USA | 6.04M | - | - | - | - | |||||
Europe and USA | - | - | - | - | - |
- Stock Market
- Equities
- DXRX Stock
- Financials Diaceutics PLC
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
